These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 11175456)
1. How schizophrenia develops: new evidence and new ideas. Harv Ment Health Lett; 2001 Feb; 17(8):1-4. PubMed ID: 11175456 [No Abstract] [Full Text] [Related]
2. Dopamine-glutamate interactions: a neural convergence mechanism of common schizophrenia risk variants. Tost H; Meyer-Lindenberg A Biol Psychiatry; 2011 May; 69(10):912-3. PubMed ID: 21515141 [No Abstract] [Full Text] [Related]
3. A glutamatergic deficiency model of schizophrenia. Carlsson A; Hansson LO; Waters N; Carlsson ML Br J Psychiatry Suppl; 1999; (37):2-6. PubMed ID: 10211132 [TBL] [Abstract][Full Text] [Related]
4. The biochemistry of schizophrenia--a review. Shelley RK; Walsh N Ir Med J; 1985 May; 78(5):139-43. PubMed ID: 3891675 [No Abstract] [Full Text] [Related]
5. Origins and perspectives of schizophrenia research. Faludi G; Dome P; Lazary J Neuropsychopharmacol Hung; 2011 Dec; 13(4):185-92. PubMed ID: 22184186 [TBL] [Abstract][Full Text] [Related]
6. The neuropathology of schizophrenia. Stevens JR Psychol Med; 1982 Nov; 12(4):695-700. PubMed ID: 7156246 [No Abstract] [Full Text] [Related]
7. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Winter C; Djodari-Irani A; Sohr R; Morgenstern R; Feldon J; Juckel G; Meyer U Int J Neuropsychopharmacol; 2009 May; 12(4):513-24. PubMed ID: 18752727 [TBL] [Abstract][Full Text] [Related]
8. [A biochemical theory of schizophrenia]. Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120 [TBL] [Abstract][Full Text] [Related]
9. N-methyl-D-aspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking. Domino EF; Mirzoyan D; Tsukada H Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):801-11. PubMed ID: 15363604 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic mechanisms in the pathogenesis of schizophrenia. Goldstein M; Deutch AY FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713 [TBL] [Abstract][Full Text] [Related]
15. Aetiology: Searching for schizophrenia's roots. Elert E Nature; 2014 Apr; 508(7494):S2-3. PubMed ID: 24695332 [No Abstract] [Full Text] [Related]
17. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review. Fredrickson P; Richelson E J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063 [TBL] [Abstract][Full Text] [Related]
18. Somatic transposition in the brain has the potential to influence the biosynthesis of metabolites involved in Parkinson's disease and schizophrenia. Abrusán G Biol Direct; 2012 Nov; 7():41. PubMed ID: 23176288 [TBL] [Abstract][Full Text] [Related]
19. [Brain of patients with chronic schizophrenia and neurotransmitters]. Toru M Seishin Shinkeigaku Zasshi; 2005; 107(10):1015-21. PubMed ID: 16381382 [No Abstract] [Full Text] [Related]
20. [Recent progresses in the biology of schizophrenia]. Bonvalot T; Zarifian E Rev Prat; 1992 May; 42(9):1139-43. PubMed ID: 1353900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]